ReactWell Licenses ORNL Catalyst for Energy Conversion Applications
ReactWell, a NOBIC client and tenant, recently announced a partnership with Oak Ridge National Lab. The Company has licensed a novel waste-to-fuel technology to improve energy conversion methods for cleaner,…
CADEX Genomics Launches Clinical Study
Cadex Genomics, a newly funded company based on technology developed in Louisiana, recently announced the launch of a clinical study at Rocky Mountain Cancer Center. The company had recently raised…
BARDA Announces Interagency Group to Battle Opioid Epidemic
The Biomedical Advanced Research and Development Authority (BARDA) is leading an interagency group to develop a wearable device to detect, and possibly treat, an opioid overdose. This group, Technology Innovation…
Gremillion Technologies Wins BioChallenge and BioFund Prizes
Local physician and entrepreneur Grayson Gremillion presented his company at the 7th annual BioChallenge pitch competition at the Joy Theater on November 14, and was selected as the winner of…
Innovation Louisiana 2018 was a Resounding Success
The 2018 edition of the New Orleans BioInnovation Center’s annual conference, Innovation Louisiana, featured speakers from Pfizer, Janssen, Enplas, the USPTO, NCI, NCATS, Harvard University, and many more, including Governor…
Bob Brickman of Postlethwaite & Netterville joins New Orleans BioInnovation Center Advisory Board
Robert (Bob) Brickman, CPA, is a Director in Postlethwaite & Netterville's Accounting and Assurance Services Group. P&N has been a long-time supporter of NOBIC, and the Center is grateful to…
NOBIC selected to accelerate innovation for U.S. health security, daily medical care
New Orleans BioInnovation Center has been selected as one of eight accelerators in the nation by the U.S. Department of Health and Human Services (HHS) to drive innovation in lifesaving…
Fluence Analytics Signs Distribution Agreement in Japan
(New Orleans) ‒ Fluence Analytics, a manufacturer of industrial and laboratory analytics products, today announced it has signed a distribution agreement with Nihon Rufuto, a Japanese company specializing in the…
NOBIC client Talaria Antibodies reaches semifinals of Delta I-Fund Demo Day
Talaria Antibodies Inc, a spin-off company from LaCell LLC, was a semi-finalist in the Delta I-Fund Demo Day competition. Dr. Shawna Wicks, President and CEO of Talaria Antibodies, and her…
NOBIC Client Zenopharm awarded $2 Million Grant
Zenopharm, a Xavier University spin-out led by Dr. Guangdi Wang, was recently awarded a $2 Million SBIR Phase II Grant from the National Cancer Institute. Zenopharm was founded in 2012 to…